COMMUNIQUÉS West-GlobeNewswire

Cidara Therapeutics to Participate in November Investor Conferences
28/10/2025
SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced [...]
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
28/10/2025
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors
28/10/2025
MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging biomedical device [...]
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
28/10/2025
-- Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of PCRX-201 -- BRISBANE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Pacira [...]
Targeted Genomics Launches CeliacDx Consumer-Initiated Testing Service
28/10/2025
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today announced the launch of their [...]
STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements
28/10/2025
HORSHAM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and [...]
Glucotrack, Inc. Reminds Shareholders to Vote
28/10/2025
The Special Meeting of Shareholders held on October 31, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: [...]
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
28/10/2025
SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third [...]
CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
28/10/2025
Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the firm Appointment adds deep business strategy, transactional, and commercial [...]
AssistRx Named a Winner of the Orlando Sentinel Media Group’s Central Florida Top Workplaces 2025 Award
28/10/2025
Healthcare technology and patient solutions provider recognized as a Central Florida top employer for fifth consecutive year ORLANDO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy initiation [...]
R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships
28/10/2025
MURRAY, Utah, Oct. 28, 2025 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the appointment of Estelle Barnes as the leader of R1’s Enterprise Customer [...]
ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs
28/10/2025
To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 [...]
Curia Releases 2024 Environmental, Social and Governance (ESG) Report
28/10/2025
ALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third Environmental, Social and [...]
Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks
28/10/2025
ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald , the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of Amazon Health services [...]
Remedy's Nutrition® Launches Premium Horse Chestnut 1000mg Capsules to Support Vein Health and Healthy Circulation
28/10/2025
KEY LARGO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary supplement company since 1972 and a leader in premium herbal formulations, today announced the launch of its high-potency [...]
Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement
28/10/2025
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced [...]
Novartis completes acquisition of Tourmaline Bio
28/10/2025
Basel, October 28, 2025 - Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common stock, par value $0. [...]
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
28/10/2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Assertio Announces Leadership Transition
28/10/2025
Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the Current Range at [...]

Pages